Cargando…

Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer

Personalised medicine, an essential component of modern thoracic oncology, has been evolving continuously ever since the discovery of the epidermal growth factor receptor and its tyrosine kinase inhibitors. Today, screening for driver alterations in patients with advanced lung adenocarcinoma as well...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdayem, Pamela, Planchard, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489045/
https://www.ncbi.nlm.nih.gov/pubmed/34289984
http://dx.doi.org/10.1183/16000617.0294-2020

Ejemplares similares